US FDA Shelves Speedy Drug Review Voucher Programme, Sources Say

RecentNews.uk

US FDA has shelved a commissioner-backed voucher programme aimed at speeding up drug reviews.

Fast-track vouchers allow companies to cut drug evaluation windows from ten months to six months.

Internal reviews and resource concerns likely prompted the decision to pause the scheme.

UK pharmaceutical firms and global biotech companies may face altered timelines for North American launches.

Should medical regulators offer fast-track vouchers to speed up drug approvals?

Tap below to vote and see what others think.